共 118 条
[1]
Kamangar F(2006)Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137-50
[2]
Dores GM(2013)Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res Treat 45 1-14
[3]
Anderson WF(1999)Chemotherapy in esophageal cancer Semin Oncol 26 12-20
[4]
Jung KW(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-46
[5]
Won YJ(1997)Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-20
[6]
Kong HJ(1998)5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research Eur J Surg 164 849-57
[7]
Oh CM(2008)A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma Cancer Chemother Pharmacol 62 77-84
[8]
Seo HG(2002)Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer Br J Cancer 86 669-73
[9]
Lee JS(2008)A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus Am J Clin Oncol 31 29-33
[10]
Enzinger PC(1998)Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts Clin Cancer Res 4 1013-9